logo

Iterum Therapeutics Plc (ITRM)



Trade ITRM now with
  Date
  Headline
7/26/2021 7:08:58 AM Iterum Therapeutics Says FDA Issues Complete Response Letter For Oral Sulopenem
2/3/2021 11:44:12 PM Iterum Therapeutics Increases Size Of Offering And Purchase On A Firm Commitment Basis 34.8 Shares At $1.15/Shr
2/1/2021 7:12:26 AM Iterum Announces Collaboration With EVERSANA To Support Oral Sulopenem Launch
1/25/2021 7:14:23 AM Iterum Says FDA Accepted For Review NDA For Sulopenem Etzadroxil/probenecid